Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05795062 · ClinicalTrials.gov registry record
Treatment Patterns Among Patients With Venous Thromboembolism in the United States
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 13,945
- Enrollment target
NCT05795062 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 13,945 participants.
The verdict
NCT05795062 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 13,945 participants
- Enrollment target
Study Summary
The purpose of this study is to assess outpatient treatment patterns following hospitalization for venous thromboembolism (VTE). VTE is a condition that occurs when blood clot forms in the vein. This is a retrospective study (assessments on events that have already occurred) of healthcare claims from databases. The study sponsors will assess healthcare claim records of patients treated with either apixaban or warfarin. Assessment includes treatment persistence, switch, and stopping therapy, along with recurrent VTE and bleeding.
Interventions
- DRUG warfarin
- DRUG apixaban
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,945 participants |
| Start Date | 2023-03-10 |
| Est. Completion | 2023-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05795062
The ClinicalTrials.gov registry entry for NCT05795062 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13,945 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which warfarin is the first listed.
NCT05795062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05795062 about?
NCT05795062 is a clinical study titled "Treatment Patterns Among Patients With Venous Thromboembolism in the United States". The purpose of this study is to assess outpatient treatment patterns following hospitalization for venous thromboembolism (VTE). VTE is a condition that occurs when blood clot forms in the vein. This is a retrospective study (assessments on events that have already occurred) of healthcare claims fr...
What is the current status of trial NCT05795062?
This trial is currently completed. The enrollment target is 13,945 participants. The study started on 2023-03-10. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT05795062?
The interventions under investigation include: warfarin (DRUG), apixaban (DRUG).
Who is sponsoring clinical trial NCT05795062?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.